Traders should watch for warrant exercises and insider selling activity; the overhang of resale shares and current stock price below exercise prices suggests near-term bearish pressure despite potential future proceeds.
Price Chart
Executive Summary
Silo Pharma's registration statement for the resale of up to 3,071,428 shares of common stock, issuable upon exercise of warrants issued in a private placement, has become effective. The shares were registered for resale by selling shareholders, not the company, though Silo may receive up to $2.38 million if all warrants are cash-exercised.
Key Facts
- EFFECT filing confirms effectiveness of registration statement S-1 (File No. 333-286777) as of April 15, 2026.
- Registration covers resale of up to 3,071,428 shares by selling shareholders, including 2,857,143 shares underlying investor warrants and 214,285 shares underlying placement agent warrants.
- Investor warrants have an exercise price of $0.75 per share; placement agent warrants at $1.0938 per share.
- Company will not receive proceeds from resale, but could receive up to $2.38 million if all warrants are cash-exercised.
- Stock price closed at $0.5690 on October 27, 2025, below both exercise prices, suggesting limited near-term incentive for cash exercise.
Financial Impact
Potential dilution of 3.07M shares; up to $2.38M in proceeds to company if all warrants are cash-exercised
Risk Factors
- Significant share dilution if warrants are exercised
- Downward price pressure from selling shareholders liquidating shares
- Low likelihood of warrant exercise given stock price below exercise thresholds
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-001189 |
| Document: 9999999995-26-001189-index.html | 9999999995-26-001189 |
| Document: 9999999995-26-001189.txt | 9999999995-26-001189 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 14, 2026 13d ago | 8-K | $1.20 | awaiting T+60 | — | $1.29 (+7.50%) |
Oct 2, 2026 25d ago | 8-K | $1.49 | awaiting T+60 | — | $1.29 (−13.42%) |
Sep 18, 2026 5w ago | Press Release | $1.84 | awaiting T+60 | — | $1.29 (−29.89%) |
Aug 7, 2026 11w ago | EFFECT | $3.74 | awaiting T+60 | — | $1.29 (−65.46%) |
Jul 14, 2026 15w ago | Press Release | $5.13 $1.44 | ▼ −71.93% | ▼ −75.31% | $1.29 (−74.85%) |
Jun 30, 2026 17w ago | DEFA14A | $6.21 $1.77 | ▲ +71.50% | ▲ +75.06% | $1.29 (+79.23%) |
Jun 3, 2026 20w ago | 8-K | $6.11 $2.54 | ▼ −58.43% | ▼ −60.31% | $1.29 (−78.89%) |
Jun 1, 2026 21w ago | 8-K | $4.99 $2.59 | ▼ −48.09% | ▼ −49.32% | $1.29 (−74.14%) |
Apr 29, 2026 25w ago | Press Release | $6.74 $4.47 | ▼ −33.63% | ▼ −37.74% | $1.29 (−80.85%) |
Apr 22, 2026 26w ago | Press Release | $7.11 $4.70 | ▼ −33.90% | ▼ −38.91% | $1.29 (−81.86%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers